Invention Grant
- Patent Title: Histone deacetylase inhibitors
-
Application No.: US15302739Application Date: 2015-04-09
-
Publication No.: US10246455B2Publication Date: 2019-04-02
- Inventor: Jing-Ping Liou , Jang-Yang Chang , Jia-Yi Wang , Yun Yen
- Applicant: Taipei Medical University , National Health Research Institutes
- Applicant Address: TW Taipei TW Zhunan
- Assignee: Taipei Medical University,National Health Research Institutes
- Current Assignee: Taipei Medical University,National Health Research Institutes
- Current Assignee Address: TW Taipei TW Zhunan
- Agency: Cesari and McKenna, LLP
- International Application: PCT/US2015/025084 WO 20150409
- International Announcement: WO2015/157504 WO 20151015
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D231/56 ; C07D209/08 ; A61K31/437

Abstract:
Fused bicycle indol, indoline, azoindole, or azoindoline compounds of Formula (I) set forth herein. Also disclosed are pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing the same. Further disclosed is a method for treating cancer, e.g., glioma, prostate cancer, and colorectal cancer, with these compounds.
Public/Granted literature
- US20170057956A1 HISTONE DEACETYLASE INHIBITORS Public/Granted day:2017-03-02
Information query